Novartis Report on Nuzzel

mobihealthnews.com - Pear Therapeutics, Novartis announce commercial launch of reSET

Pear Therapeutics, Novartis announce commercial launch of reSET

MobiHealthNews
mobihealthnews.com - Alphabet's Verily shelves glucose-sensing contact lens project with Novartis

Alphabet's Verily shelves glucose-sensing contact lens project with Novartis

MobiHealthNews
forbes.com - Michela Tindera - It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project

It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project

Forbes – Michela Tindera
mddionline.com - Verily and Novartis Halt Glucose Detection Lens Work

Verily and Novartis Halt Glucose Detection Lens Work

MDDI Online
pharmatimes.com - NICE issues final draft guidelines for Novartis' Kymriah

NICE issues final draft guidelines for Novartis' Kymriah

PharmaTimes
pharmaphorum.com - Novartis focusing on cutting CAR-T costs ahead of EU launches - Pharmaphorum

Novartis focusing on cutting CAR-T costs ahead of EU launches - Pharmaphorum

pharmaphorum.com
endpts.com - John Carroll - - Novartis-backed Inflazome raises $46M for their clinical challenge to prove NLRP3 is a great anti-inflammatory target

Novartis-backed Inflazome raises $46M for their clinical challenge to prove NLRP3 is a great anti-inflammatory target

Endpoints News – John Carroll -
reuters.com - John Miller - Novartis launches third-to-market Remicade copy in Germany

Novartis launches third-to-market Remicade copy in Germany

Reuters – John Miller
handelszeitung.ch - Verily: Novartis-Projekt mit Google wird abgebrochen

Verily: Novartis-Projekt mit Google wird abgebrochen

Handelszeitung

Top Sources reporting on Novartis

Name
1 aktiencheck.de
2 Reuters
3 Endpoints News
4 STAT
5 finanzen.net
6 cash
7 EIN News
8 Bloomberg.com
9 olympia.gr